Application of short peptide asp-his-tyr in preparation of medicine for treating polycystic ovary syndrome
An asp-his-tyr, polycystic ovary technology, applied in the field of biomedicine, can solve the problems of poor curative effect, achieve the effect of reversing insulin resistance and improving polycystic ovary syndrome
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0018] Three-week-old SD rats were selected to prepare polycystic ovary syndrome insulin resistance animal models, and drug intervention was performed on the successful model mice.
[0019] ELISA and other methods were used for detection, and statistical software SPSS19.0 was used for analysis to clarify the therapeutic effect and possible mechanism of the short peptide Asp-His-Tyr on polycystic ovary syndrome insulin resistance animal models.
[0020] 1. Materials
[0021] 1.1 Experimental animals
[0022] 120 3-week-old SPF female SD rats were raised in the Animal Center of the First Affiliated Hospital of Heilongjiang University of Traditional Chinese Medicine. 25°C constant temperature (50% humidity) clean-grade breeding, without feeding vitamin products, 12h light and 12h dark cycle alternately.
[0023] 1.2 Main reagents
[0024] Dehydroepiandrosterone (Sigma Company), short peptide Asp-His-Tyr (Shanghai Sangong Synthetic), metformin (Shanghai Ziyi Co., Ltd.), blood g...
PUM
Login to View More Abstract
Description
Claims
Application Information
Login to View More 
